Bristol Myers Squibb BMY
NYSE BMY
$62.93 -0.50 (-0.79%)
At close: Nov 16, 2026 · 4:00 PM EST

Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026)

Updated

Bristol Myers Squibb's Capital Expenditures came in at $344 million for Q3 2026, up 7.5% from $320 million a year earlier and up 12.8% from the prior quarter.

Analysis

Bristol Myers Squibb (BMY) Capital Expenditures (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Bristol Myers Squibb reported Capital Expenditures of $1.37 billion, up 3.6% year-over-year; for FY2025, it was $1.31 billion, up 5.0% from FY2024.

  • Capital Expenditures has increased in each of the last five years, with a five-year compound annual growth rate of 11.7% (FY2020 to FY2025).
  • Going back by year, Capital Expenditures was $1.25 billion in FY2024 (+3.2%), $1.21 billion in FY2023 (+8.1%), $1.12 billion in FY2022 (+14.9%) and $973 million in FY2021 (+29.2%).
  • The five-year range for quarterly Capital Expenditures is $247 million (Q3 2022) to $378 million (Q4 2024).
  • Year-over-year, Capital Expenditures increased in four of the last eight quarters, with growth averaging 8.2%.
  • The fastest year-over-year change in Capital Expenditures over five years came in Q1 2022 (growth of 46.2%), and the weakest in Q2 2026 (a decline of 15.5%).
  • Business Quant data shows BMY's Capital Expenditures at $305 million (Q2 2026), $347 million (Q1 2026) and $370 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.36 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 301.00 Mn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -3.30 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 237.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 573.00 Mn
10 Bristol Myers Squibb 128.63 Bn 83.82 Bn 8.92 Bn 344.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 344.00 Mn
Jun 30, 2026 305.00 Mn
Mar 31, 2026 347.00 Mn
Dec 31, 2025 370.00 Mn
Sep 30, 2025 320.00 Mn
Jun 30, 2025 361.00 Mn
Mar 31, 2025 260.00 Mn
Dec 31, 2024 378.00 Mn
Sep 30, 2024 324.00 Mn
Jun 30, 2024 262.00 Mn
Mar 31, 2024 284.00 Mn
Dec 31, 2023 330.00 Mn
Sep 30, 2023 342.00 Mn
Jun 30, 2023 259.00 Mn
Mar 31, 2023 278.00 Mn
Dec 31, 2022 346.00 Mn
Sep 30, 2022 247.00 Mn
Jun 30, 2022 272.00 Mn
Mar 31, 2022 253.00 Mn
Dec 31, 2021 320.00 Mn
API Access

Bristol Myers Squibb Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=BMY&period=max&api_key=YOUR_API_KEY